Pine Valley Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.71M | Buy |
6,612
+1,309
| +25% | +$932K | 0.28% | 86 |
|
|
2024
Q3 | $5.57M | Buy |
5,303
+848
| +19% | +$891K | 0.34% | 70 |
|
|
2024
Q2 | $4.68M | Buy |
4,455
+626
| +16% | +$658K | 0.31% | 72 |
|
|
2024
Q1 | $3.69M | Buy |
3,829
+380
| +11% | +$366K | 0.25% | 87 |
|
|
2023
Q4 | $3.03M | Buy |
3,449
+536
| +18% | +$471K | 0.22% | 92 |
|
|
2023
Q3 | $2.4M | Buy |
2,913
+992
| +52% | +$816K | 0.22% | 103 |
|
|
2023
Q2 | $1.38M | Buy |
1,921
+53
| +3% | +$38.1K | 0.14% | 151 |
|
|
2023
Q1 | $1.17M | Buy |
+1,868
| New | +$1.17M | 0.17% | 112 |
|